Related Experiment Video
Updated: Jul 17, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Roles of salt‑inducible kinases in cancer (Review)
Shenghui Feng1, Fangyi Wei1, Haoran Shi1
1Department of Gastroenterology, Research Institute of Digestive Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Abstract:
Salt inducible kinases (SIKs) with three subtypes SIK1, SIK2 and SIK3, belong to the AMP‑activated protein kinase family. They are expressed ubiquitously in humans. Under normal circumstances, SIK1 regulates adrenocortical function in response to high salt or adrenocorticotropic hormone stimulation, SIK2 is involved in cell metabolism, controlling insulin signaling and gluconeogenesis and SIK3 coordinates with the mTOR complex, promoting cancer. The dysregulation of SIKs has been widely detected in various types of cancers. Based on most of the existing studies, SIK1 is mostly considered a tumor inhibitor, SIK2 and SIK3 are usually associated with tumor promotion. However, the functions of SIKs have shown contradictory in certain tumors, suggesting that SIKs cannot be simply classified as oncogenes or tumor suppressor genes. The present review provided a comprehensive summary of the roles of SIKs in the initiation and progression of different cancers, aiming to elucidate their clinical value and discuss potential strategies for targeting SIKs in cancer therapy.
Insights
Salt inducible kinases (SIKs) play complex roles in cancer, with subtypes SIK1, SIK2, and SIK3 exhibiting dual functions. This review explores their clinical value and therapeutic potential in oncology.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Salt inducible kinases (SIKs), comprising SIK1, SIK2, and SIK3, are ubiquitous AMP‑activated protein kinase family members.
- SIK1 regulates adrenocortical function, SIK2 impacts cell metabolism (insulin signaling, gluconeogenesis), and SIK3 promotes cancer via mTOR.
- Dysregulation of SIKs is prevalent in various cancers, with SIK1 often acting as a tumor inhibitor and SIK2/SIK3 as promoters.
Approach:
- Comprehensive review of existing literature on SIK functions in cancer initiation and progression.
- Analysis of contradictory roles of SIKs, challenging simple oncogene/tumor suppressor classification.
- Elucidation of clinical value and potential therapeutic strategies targeting SIKs.
Key Points:
- SIKs exhibit context-dependent roles in tumorigenesis, not fitting simple oncogene or tumor suppressor paradigms.
- SIK1's function can be tumor suppressive, while SIK2 and SIK3 are frequently oncogenic.
- The precise roles of SIKs vary significantly across different cancer types.
Conclusions:
- SIKs represent a complex family of kinases with significant implications in cancer.
- Understanding the nuanced functions of SIK subtypes is crucial for developing targeted cancer therapies.
- Further research into SIKs may unlock novel therapeutic strategies for various malignancies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

